Search
for
Sort by
Research 271–300 of 955
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Aging of hair
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Nutritional management in women with polycystic ovary syndrome: A review study
- The effect of metformin on hirsutism in polycystic ovary syndrome
- Polycystic Ovarian Syndrome
- Hormonal contraceptives: pharmacology tailored to women's health
- Polycystic Ovary Syndrome
- Hair Loss in Women
- Steroid Biomarkers and Genetic Studies Reveal Inactivating Mutations in Hexose-6-Phosphate Dehydrogenase in Patients with Cortisone Reductase Deficiency
- Acne and Systemic Disease
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- Insulin Resistance and Skin Diseases
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- Polycystic ovary syndrome and impact on health
- Mood and Sexual Function in Polycystic Ovary Syndrome
- Dermatology of androgen-related disorders
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Folliculitis
- How should postmenopausal androgen excess be evaluated?
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial